Xeris Pharmaceuticals shares latest product and partnership updates

News Direct

Mon, Jun 19, 2023, 12:58 PM1 min read

In this article:

New York --News Direct-- Xeris Biopharma Holdings

Xeris Pharmaceuticals chairman and CEO Paul Edick joins Natalie Stoberman from the Proactive studios to discuss the latest updates on product line performance.

Xeris is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing differentiated and innovative products across a range of therapies. Xeris has three commercially available products: Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis, a proven therapy for primary periodic paralysis; and Recorlev for the treatment of endogenous Cushing’s syndrome. Xeris has a pipeline of development and partnered programs using its formulation sciences, XeriSol and XeriJect, to support long-term product development and commercial success.

Contact Details

Proactive Investors

+1 347-449-0879

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/xeris-pharmaceuticals-shares-latest-product-and-partnership-updates-413821847

Trump to set interest rates himself under secret presidential plan
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The Telegraph•18h ago
2 Stock-Split Stocks to Buy Hand Over Fist Right Now
These proven wealth builders could be exactly what you're searching for right now.
Motley Fool•22h ago
Walmart CEO started his career unloading trailers at the warehouse—he says he got promotion after promotion by raising his hand when his boss was out of town
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Fortune•1d ago
Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•2h ago
Analysts revamp Microsoft stock price target after earnings
Here's what could happen next to Microsoft shares.
TheStreet•12h ago
Housing supply surges by up to 50% in these metro areas — and many sellers are being forced to slash their asking prices
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
MarketWatch•1d ago
Bank of America lays out the exact scenario that could finally pop the stock market's AI bubble
It's been an "everything buy bonds" bull rally in markets for months, but BofA is cautiously watching a couple of indicators.
Business Insider•10h ago
Meet the 2 Best S&P 500 Stocks of 2024. They Could Soar Another 69% and 91%, According to Certain Wall Street Analysts.
Nvidia and Super Micro Computer have been the best-performing S&P 500 stocks of 2024, but select Wall Street analysts still see substantial upside for shareholders.
Motley Fool•3h ago
Why I Just Added This Ultra-High-Yield Dividend ETF to My Retirement Account
The JPMorgan Nasdaq Equity Premium Income ETF offers a compelling blend of income and upside to my portfolio.
Motley Fool•4h ago
Departing top Tesla exec cashes out almost his entire stake for $181 million as longtime bull Ron Baron calls bottom in the stock
Baron, whose largest position is in Tesla, is betting the new shift in strategy for Tesla’s low-cost car will fill its increasingly empty factories.
Fortune•23h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Xeris Pharmaceuticals shares latest product and partnership updates

Contact Details

Recommended Stories

Trump to set interest rates himself under secret presidential plan

2 Stock-Split Stocks to Buy Hand Over Fist Right Now

Walmart CEO started his career unloading trailers at the warehouse—he says he got promotion after promotion by raising his hand when his boss was out of town

Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead

Analysts revamp Microsoft stock price target after earnings

Housing supply surges by up to 50% in these metro areas — and many sellers are being forced to slash their asking prices

Bank of America lays out the exact scenario that could finally pop the stock market's AI bubble

Meet the 2 Best S&P 500 Stocks of 2024. They Could Soar Another 69% and 91%, According to Certain Wall Street Analysts.

Why I Just Added This Ultra-High-Yield Dividend ETF to My Retirement Account

Departing top Tesla exec cashes out almost his entire stake for $181 million as longtime bull Ron Baron calls bottom in the stock